Industry Expertise — Health Tech
Health Tech Marketing & Growth
Strategic marketing consulting for health tech CEOs who need their commercial investment to drive measurable pipeline and revenue.
The Situation
You Built Technology That Solves a Real Problem. Why Isn't It Selling?
Your platform works. The technology is sound. Early customers see the value. Your team has poured blood, sweat and perhaps tears into building something that genuinely improves how healthcare systems or clinics operate.
But growth has stalled. Enterprise deals take eighteen months to close. Pilots convert at disappointing rates. Maybe customer churn is high. Your sales team spends more time educating prospects than closing them. Marketing generates interest, but qualified pipeline remains thin. Customer acquisition costs keep climbing while your runway shrinks.
This is not a product problem. This is a commercial architecture problem.
Health tech companies face a buying environment unlike any other industry. Your buyers are risk-averse by training and regulation. Their purchasing processes involve IT security reviews, clinical validation committees, compliance officers, and C-suite approvals. The stakeholders who feel your product's pain rarely control the budget. And the stakeholders who control the budget rarely feel the pain.
The companies winning in this environment are not simply building better products or hiring more salespeople. They are building integrated commercial systems that generate qualified demand, equip sales with the right tools for every stakeholder, and create urgency through ROI evidence that resonates with economic buyers.
The Real Barriers
Five Growth Challenges to Health Tech Growth — Many Face Several at Once
01
Undefined or Misaligned Ideal Customer Profile
Your sales team is pursuing any health system, practice, or payer that might buy. Some deals close in months; others consume enormous resources and go nowhere. Without a rigorous ICP, marketing cannot target effectively, sales cannot prioritize intelligently, and leadership cannot forecast accurately. Every downstream commercial activity suffers.
02
Demand Generation That Does Not Generate Demand
Marketing runs campaigns, produces thought leadership, sponsors conferences, builds email lists. But qualified pipeline is not materializing. The activities look right. The results are wrong. There is a disconnect between marketing activity and commercial outcomes that nobody has diagnosed or fixed.
03
Stakeholder Messaging That Misses the Mark
Your product messaging resonates with the end users who would benefit daily. But the CIO needs security and integration assurance. The CFO needs ROI quantification. The CMO needs clinical workflow validation. The compliance officer needs regulatory confidence. You have one message when you need five, each tailored to what that stakeholder actually cares about.
04
Awareness Challenges and Getting the Attention of Decision-Makers
These days, healthcare professionals are insulated from business development professionals because they are over-worked. There are too many people trying to get their attention. That's true for the clinical providers and the top administrative leaders. Without awareness, you can't get those 1:1 meetings to tell them the story.
05
Pilot Conversions That Stall
You land pilots, but they don't convert to enterprise contracts. The pilot proves the technology works, but organizational inertia takes over. Champions leave or get reassigned. Budget cycles reset. Competing priorities emerge. Your pipeline is full of "successful" pilots that never become revenue. Ongoing funding depends upon your company demonstrating revenue growth and solid EBITDA.
Our Approach
A Commercial Growth Approach Built for Health Tech Realities
Novastrat Growth works with health tech CEOs to build commercial systems that generate qualified demand, accelerate pipeline velocity, and improve conversion at every stage of the buying process.
We developed the MAPS Framework specifically to address the interconnected commercial challenges that health tech companies face. MAPS provides a structured approach to aligning your commercial investment with measurable outcomes.
Our Health Tech Commercial Practice Focuses On
Where We Focus
01
Ideal Customer Profile Development
Rigorous analysis to define which organizations represent your highest probability, highest value opportunities. We examine technology readiness, budget authority, competitive dynamics, regulatory environment, and strategic priorities to build an ICP that focuses your entire commercial operation on winnable business.
02
Demand Generation Strategy
Design of integrated demand generation programs that reach the right organizations with the right message through the right channels. We connect digital marketing, content strategy, conference presence, thought leadership, and sales development into a coordinated system that fills pipeline with qualified opportunities.
03
Stakeholder Messaging Architecture
Development of tailored messaging for every stakeholder in the health tech buying process. Clinical end users, IT leaders, CIOs, CFOs, CMOs, compliance officers, and CEOs all require different evidence and different framing. We build the messaging infrastructure that equips your team for every conversation.
04
ROI and Business Case Development
Creation of economic evidence and business case tools that accelerate purchasing decisions. This includes total cost of ownership models, ROI calculators, implementation cost frameworks, and outcome projections formatted for executive review. We help you win in the room where budget decisions are actually made.
05
Digital Marketing and Awareness Building
Strategy for building market awareness among target organizations through digital channels. We design approaches that establish thought leadership, generate inbound interest, and support sales efforts with prospects who already understand your differentiation before the first conversation.
06
Pilot-to-Enterprise Conversion Strategy
Systematic approach to converting pilots into enterprise contracts. We help you design pilot structures that build organizational momentum, identify and engage economic buyers early, create urgency through defined success metrics, and navigate the transition from proof-of-concept to procurement.
07
Pipeline Optimization and Conversion Improvement
Analysis of your current pipeline to identify where deals stall, why they stall, and what interventions will accelerate movement. We examine stage conversion rates, time in stage, competitive loss patterns, and rep productivity to find the leverage points that will improve commercial performance.
08
Lowering Customer Acquisition Cost
Systematic reduction of CAC through better targeting, higher conversion rates, and more efficient channel spend. We identify where your commercial dollars are wasted on low-probability prospects and redesign resource allocation to acquire customers at a cost that supports sustainable growth and healthy unit economics.
09
Increasing Customer Lifetime Value
Strategy for expanding revenue from existing accounts through deeper penetration, expanded utilization, product extensions, and stronger retention. We help you build the post-sale engagement model that transforms initial implementations into enterprise-wide deployments and long-term partnerships.
10
KPI Visibility and Agile Decision Making
Design of commercial dashboards and reporting structures that give leadership real-time visibility into pipeline health, conversion metrics, and leading indicators. We help you build the measurement infrastructure that enables quick pivots when market signals change or commercial experiments need adjustment.
11
Market Analysis
Deep examination of market size, segment dynamics, growth trajectories, and technology adoption patterns. We provide the market intelligence foundation that informs ICP development, positioning decisions, and resource allocation across segments and buyer types.
12
Competitive Analysis
Rigorous assessment of competitor positioning, messaging, pricing, integration capabilities, and customer base. We identify competitive vulnerabilities, differentiation opportunities, and the specific battlegrounds where you can win. Your sales team gains actionable intelligence for every competitive encounter.
13
Building a Brand
Development of brand positioning and identity that establishes your company as a credible, differentiated player in your category. We help health tech companies build brands that resonate with clinical, technical, and economic buyers, support premium positioning, and create preference before the sales conversation begins.
13
Channel Optimization
Analysis and refinement of your go-to-market strategy to maximize reach and efficiency. Whether you sell direct, through channel partners, through health system innovation programs, or through a hybrid model, we help you optimize your approach and ensure your strategy aligns with your ICP and growth objectives.
Fit
Who We Work With
Our health tech clients typically share several characteristics. We work directly with CEOs, often alongside Chief Commercial Officers, VP Marketing leaders, or investors who recognize that incremental improvements will not solve structural commercial challenges.
Revenue between $10M and $300M, or earlier stage companies with institutional backing preparing for commercial scale.
VC-backed, PE-backed, or founder-led with growth expectations that current commercial performance is not meeting.
Technology that is clinically differentiated but commercial traction that lags the opportunity.
Sales teams that are capable but lack the targeting, tools, and support infrastructure to perform at their potential.
The Novastrat Growth Engagement Model
A Structured Approach: Our MAPS Framework That Moves Efficiently From Diagnosis to Strategy to Execution
Phase 1 — "Measure"
Commercial Diagnostic
A focused four-to-six week assessment of your current commercial performance, ICP definition, demand generation effectiveness, stakeholder messaging, and pipeline dynamics. We identify the highest leverage opportunities and the specific barriers preventing you from capturing them.
Phase 2 — "Assess and Prioritize"
Strategy Architecture
Development of a comprehensive commercial growth plan built on the MAPS Framework. This includes ICP documentation, demand generation program design, stakeholder messaging architecture, ROI tool development, and execution milestones. Any gaps in people, processes, or technology are identified, including AI. This becomes your working roadmap.
Phase 3 — "Scale" (optional)
Execution Partnership
For CEOs who want ongoing strategic support, we provide continued engagement to track progress, refine strategy as market feedback accumulates, and help navigate execution challenges as your commercial capabilities mature.
Not Sure Which Fits
Start a Conversation
If your health tech company has strong technology but commercial results that are not matching the opportunity, let's talk. A thirty-minute conversation will help us understand your situation and determine whether Novastrat Growth can add value.
FAQ
Frequently Asked Questions
How is Novastrat Growth different from health tech marketing agencies?
Marketing agencies execute campaigns. We design commercial strategy. Agencies are valuable partners for content production, digital advertising, conference logistics, and creative development. But they typically work from a brief that someone needs to write. We help CEOs and commercial leaders define the strategy that should guide all marketing execution. Many of our clients engage agencies to execute the programs we help design.
Do you replace our internal marketing team?
No. We work alongside internal marketing and commercial teams to elevate their strategic foundation. Our goal is to provide the ICP clarity, messaging architecture, and demand generation strategy that makes your internal team dramatically more effective. We are not competing with your marketing leader; we are equipping them to succeed.
What types of health tech companies do you work with?
We work across health tech segments including health operating systems, AI technologies, clinical decision support, patient engagement and review platforms, telehealth, remote patient monitoring, population health, healthcare analytics, and administrative workflow automation. The common thread is technology that sells into healthcare organizations and faces complex, multi-stakeholder buying processes.
How do you approach ROI and business case development?
We help companies build the economic evidence and presentation tools that healthcare buyers require. This includes developing total cost of ownership models, creating ROI frameworks tailored to different buyer contexts (health systems, physician practices, payers), building evidence summaries that address common objections, and preparing sales teams to present effectively in executive settings. For companies without internal resources for this work, we can develop these capabilities. For companies with existing resources, we help integrate business case tools into the broader commercial strategy.
What is the MAPS Framework?
MAPS is our proprietary framework for diagnosing and addressing commercial growth challenges. It provides a structured approach to understanding where commercial performance is breaking down and what interventions will have the highest impact. You can explore the framework in detail on our MAPS Framework page.
How long does a typical engagement last?
The Commercial Diagnostic phase typically takes four to six weeks. Strategy Architecture requires an additional six to ten weeks depending on complexity. Many clients continue with Execution Partnership engagements as they implement commercial changes and refine their approach based on market results.
What outcomes should I expect?
Specific outcomes depend on your situation. Clients typically achieve a documented ICP that focuses commercial resources on winnable accounts, stakeholder messaging that equips sales for every conversation in the buying process, demand generation programs that fill pipeline with qualified opportunities, and ROI tools that accelerate purchasing decisions. Within twelve to eighteen months of implementation, successful engagements show measurable improvement in pipeline quality, stage conversion rates, sales cycle length, customer acquisition cost, lifetime value, and revenue growth.
Do you work with investors on portfolio company commercial strategy?
Yes. We engage with venture capital and private equity firms on commercial strategy for portfolio companies, commercial due diligence for prospective investments, and post-investment commercial capability building.
How is selling health tech different from selling other B2B software?
Healthcare buyers face unique constraints that extend sales cycles and complicate purchasing decisions. Security and compliance requirements (HIPAA, HITRUST, SOC 2) create additional evaluation hurdles. Clinical workflow integration requires validation from multiple departments. Budget cycles in healthcare organizations often move slowly, and purchasing authority is distributed across IT, clinical, financial, and operational leadership. Success requires commercial approaches specifically designed for these realities, not generic B2B SaaS playbooks.
Ready to Replace Random Acts of Marketing
With a System That Works?
Every engagement is scoped to your company, your stage, and your pace.
The first conversation is a fit check, not a pitch.